What are the main components of AVEMARs mode of action?
• Where is AVEMAR’s place in oncotherapy? Avemar is not a chemoterapeutic agent, but a supportive product that is non-toxic and possesses a number of specific advantages. Oncotherapy performed in parallel with Avemar is proven to be more effective in most cases than onco-logical therapy on its own. It can be administered in cases when active oncotherapy is no longer an option. Avemar treatment cannot be regarded as an alternative therapy, nor is it a cancer treatment method of unproven effect. Back to the top • Based on clinical experience, which type of cancers have the best response rate to AVEMAR treatment? As is indicated in the instructions accompanying Avemar, its known beneficial effects and lack of toxic side effects renders the application of Avemar both possible and permissable for all types of tumors. Naturally, we have the most experience with diseases in which Avemar was used in the frame of clinical trials, namely gastrointestinal cancers (especially colorectal cancer), s
